Home・Stock List・Globus Medical Inc (Class A)

Globus Medical Inc (Class A)

Open

SectorHealthcare

85.54 3.86

Buy Sell

Overview

Share price change

24h

Current

Min

80.69

Max

84.11

Key metrics
By Trading Economics
Income	-16M 124M
Sales	-67M 760M
P/E Sector Avg	19.033 68.51
EPS	1.12
Profit margin	16.359
Employees	6,000
EBITDA	-17M 227M

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+26.4% upside

Dividends
By Acuity
Next Earnings	5 Nov 2026

Market Stats
By TradingEconomics
Market Cap	-1.2B 11B
Previous open	81.68
Previous close	85.54

News Sentiment

By Acuity

21%

79%

26 / 340 Healthcare

Globus Medical Inc (Class A) Chart

Past performance is not a reliable indicator of future results.

Related News

7 Aug 2026, 20:03 UTC

News

Globus Medical shares rise as Stifel raises price target to $85. The company reported strong Q2 results, exceeding EPS expectations and reaffirming revenue guidance.

6 Aug 2026, 23:11 UTC

News

Globus Medical reported adjusted EPS of $1.34, surpassing estimates. The company raised its full-year EPS guidance and shares are higher in after-market hours.

5 Aug 2026, 19:52 UTC

Globus Medical Inc. shares are lower as Health Care Equipment sub-sector weakness drives the decline. Earlier, the stock rebounded from a session high.

3 Aug 2026, 19:51 UTC

Health Care Equipment gains lift Globus Medical Inc during Monday's session. The stock continues to advance, reflecting strength above its 20-day moving average.

31 Jul 2026, 20:06 UTC

News

Shares of Globus Medical Inc are lower today despite strong revenue growth and new product launches, amid investor caution over broader market dynamics.

30 Jul 2026, 19:18 UTC

Globus Medical Inc shares are lower, continuing a downward trend since Wednesday's close amid broader market volatility and geopolitical tensions.

29 Jul 2026, 17:26 UTC

Correlated Moves

Shares of Globus Medical Inc. are lower today following a slight decline in first-quarter results. The stock has pulled back from earlier session highs.

28 Jul 2026, 19:16 UTC

News

UBS initiated coverage of Globus Medical Inc with a Neutral rating and a price target of $82.00, as shares traded higher today.

27 Jul 2026, 19:06 UTC

Globus Medical Inc shares are higher, benefiting from a broader market response to declining crude oil prices. Earlier, shares peaked before pulling back slightly.

24 Jul 2026, 18:36 UTC

Globus Medical Inc shares are higher during Friday's session, continuing an upward trend since Thursday's close, despite a slight pullback earlier in the session.

20 Jul 2026, 18:46 UTC

Correlated Moves

Globus Medical shares are lower following first-quarter results, which showed a modest decline in performance. Broader market sentiment may also be influencing the stock.

Peer Comparison

Price change

Globus Medical Inc (Class A) Forecast

Price Target

By TipRanks

26.4% upside

12 Months Forecast

Average 104.09 USD 26.4%

High 123 USD

Low 82 USD

Based on 13 Wall Street analysts offering 12 month price targets forGlobus Medical Inc (Class A) - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

13 ratings

Buy

Hold

Sell

Based on 13 analysts giving stock ratings to Globus Medical Inc (Class A) - Dist in the past 3 months.

Sentiment

By Acuity

26 / 340 Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Globus Medical Inc (Class A)

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.